References
1. Bylund S, Kobyletzki LB, Svalstedt M, et al. Prevalence and Incidence
of Atopic Dermatitis: A Systematic Review. Acta Derm Venereol2020; 100: adv00160. 2020/05/16. DOI: 10.2340/00015555-3510.
2. Langan SM, Irvine AD and Weidinger S. Atopic dermatitis.Lancet 2020; 396: 345-360. 2020/08/03. DOI:
10.1016/s0140-6736(20)31286-1.
3. Zheng T YJ, Hee Oh M, Zhu Z The atopic march: progression from atopic
dermatits to allergic rhinitis and asthma. Allergy Asthma Immunol
Res 2011; 3: 67-73.
4. Andersen YMF EA, Skov L, Thyssen JP Comorbidities of Atopic
Dermatitis: Beyond Rhinitis and Asthma. Curr Derm Rep 2017; 6:
35-41.
5. Weidinger S, Beck LA, Bieber T, et al. Atopic dermatitis. Nat
Rev Dis Primers 2018; 4: 1-1. 2018/06/23. DOI:
10.1038/s41572-018-0001-z.
6. Lack G, Fox D, Northstone K, et al. Factors associated with the
development of peanut allergy in childhood. The New England
journal of medicine 2003; 348: 977-985. 2003/03/15. DOI:
10.1056/NEJMoa013536.
7. Gallo RL. Human Skin Is the Largest Epithelial Surface for
Interaction with Microbes. The Journal of investigative
dermatology 2017; 137: 1213-1214. 2017/04/12. DOI:
10.1016/j.jid.2016.11.045.
8. Naik S, Bouladoux N, Wilhelm C, et al. Compartmentalized control of
skin immunity by resident commensals. Science 2012; 337:
1115-1119. 2012/07/28. DOI: 10.1126/science.1225152.
9. Severn MM, Williams MR, Shahbandi A, et al. The Ubiquitous Human Skin
Commensal Staphylococcus hominis Protects against Opportunistic
Pathogens. mBio 2022; 13: e0093022. 2022/05/25. DOI:
10.1128/mbio.00930-22.
10. Kobayashi T, Glatz M, Horiuchi K, et al. Dysbiosis and
Staphylococcus aureus Colonization Drives Inflammation in Atopic
Dermatitis. Immunity 2015; 42: 756-766. 2015/04/23. DOI:
10.1016/j.immuni.2015.03.014.
11. Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin
microbiome associated with disease flares and treatment in children with
atopic dermatitis. Genome Res 2012; 22: 850-859. 2012/02/09. DOI:
10.1101/gr.131029.111.
12. Chng KR, Tay AS, Li C, et al. Whole metagenome profiling reveals
skin microbiome-dependent susceptibility to atopic dermatitis flare.Nat Microbiol 2016; 1: 16106-16106. 2016/08/27. DOI:
10.1038/nmicrobiol.2016.106.
13. Tay ASL, Li C, Nandi T, et al. Atopic dermatitis microbiomes
stratify into ecologic dermotypes enabling microbial virulence and
disease severity. Journal of Allergy and Clinical Immunology2020. DOI: 10.1016/j.jaci.2020.09.031.
14. Uberoi A, Bartow-McKenney C, Zheng Q, et al. Commensal microbiota
regulates skin barrier function and repair via signaling through the
aryl hydrocarbon receptor. Cell Host Microbe 2021; 29:
1235-1248.e1238. 2021/07/03. DOI: 10.1016/j.chom.2021.05.011.
15. Yu J, Luo Y, Zhu Z, et al. A tryptophan metabolite of the skin
microbiota attenuates inflammation in patients with atopic dermatitis
through the aryl hydrocarbon receptor. J Allergy Clin Immunol2019; 143: 2108-2119.e2112. 2018/12/24. DOI: 10.1016/j.jaci.2018.11.036.
16. Miajlovic H, Fallon PG, Irvine AD, et al. Effect of filaggrin
breakdown products on growth of and protein expression by Staphylococcus
aureus. J Allergy Clin Immunol 2010; 126: 1184-1190.e1183.
2010/11/03. DOI: 10.1016/j.jaci.2010.09.015.
17. Totte JE, van der Feltz WT, Hennekam M, et al. Prevalence and odds
of Staphylococcus aureus carriage in atopic dermatitis: a systematic
review and meta-analysis. Br J Dermatol 2016 2016/03/20. DOI:
10.1111/bjd.14566.
18. Cho SH, Strickland I, Boguniewicz M, et al. Fibronectin and
fibrinogen contribute to the enhanced binding of Staphylococcus aureus
to atopic skin. J Allergy Clin Immunol 2001; 108: 269-274.
2001/08/10. DOI: 10.1067/mai.2001.117455.
19. Baurecht H, Rühlemann MC, Rodríguez E, et al. Epidermal lipid
composition, barrier integrity, and eczematous inflammation are
associated with skin microbiome configuration. J Allergy Clin
Immunol 2018; 141: 1668-1676.e1616. 2018/02/09. DOI:
10.1016/j.jaci.2018.01.019.
20. Byrd AL, Deming C, Cassidy SKB, et al. Staphylococcus aureus and
Staphylococcus epidermidis strain diversity underlying pediatric atopic
dermatitis. Sci Transl Med 2017; 9 2017/07/07. DOI:
10.1126/scitranslmed.aal4651.
21. Oh J, Freeman AF, Park M, et al. The altered landscape of the human
skin microbiome in patients with primary immunodeficiencies.Genome Res 2013; 23: 2103-2114. 2013/10/31. DOI:
10.1101/gr.159467.113.
22. Tham KC, Lefferdink R, Duan K, et al. Distinct skin microbiome
community structures in congenital ichthyosis. Br J Dermatol2022; 187: 557-570. 2022/05/29. DOI: 10.1111/bjd.21687.
23. Leyden JJ, Marples RR and Kligman AM. Staphylococcus aureus in the
lesions of atopic dermatitis. Br J Dermatol 1974; 90: 525-530.
1974/05/01. DOI: 10.1111/j.1365-2133.1974.tb06447.x.
24. Cheung GYC, Bae JS and Otto M. Pathogenicity and virulence of
Staphylococcus aureus. Virulence 2021; 12: 547-569. 2021/02/02.
DOI: 10.1080/21505594.2021.1878688.
25. Key FM, Khadka VD, Romo-González C, et al. On-person adaptive
evolution of Staphylococcus aureus during treatment for atopic
dermatitis. Cell Host Microbe 2023; 31: 593-603.e597. DOI:
10.1016/j.chom.2023.03.009.
26. Saheb Kashaf S, Harkins CP, Deming C, et al. Staphylococcal
diversity in atopic dermatitis from an individual to a global scale.Cell Host Microbe 2023; 31: 578-592.e576. DOI:
10.1016/j.chom.2023.03.010.
27. Wollenberg A, Zoch C, Wetzel S, et al. Predisposing factors and
clinical features of eczema herpeticum: a retrospective analysis of 100
cases. J Am Acad Dermatol 2003; 49: 198-205. 2003/08/02. DOI:
10.1067/s0190-9622(03)00896-x.
28. Beck LA, Boguniewicz M, Hata T, et al. Phenotype of atopic
dermatitis subjects with a history of eczema herpeticum. J Allergy
Clin Immunol 2009; 124: 260-269, 269.e261-267. 2009/06/23. DOI:
10.1016/j.jaci.2009.05.020.
29. Schlievert PM, Roller RJ, Kilgore SH, et al. Staphylococcal TSST-1
Association with Eczema Herpeticum in Humans. mSphere 2021; 6:
e0060821. 2021/07/29. DOI: 10.1128/mSphere.00608-21.
30. Bin L, Kim BE, Brauweiler A, et al. Staphylococcus aureus α-toxin
modulates skin host response to viral infection. J Allergy Clin
Immunol 2012; 130: 683-691.e682. 2012/07/31. DOI:
10.1016/j.jaci.2012.06.019.
31. Tao R, Li R and Wang R. Dysbiosis of skin mycobiome in atopic
dermatitis. Mycoses 2022; 65: 285-293. 2021/11/25. DOI:
10.1111/myc.13402.
32. Li H, Goh BN, Teh WK, et al. Skin Commensal Malassezia globosa
Secreted Protease Attenuates Staphylococcus aureus Biofilm Formation.Journal of Investigative Dermatology 2018; 138: 1137-1145. DOI:
10.1016/j.jid.2017.11.034.
33. Sparber F, De Gregorio C, Steckholzer S, et al. The Skin Commensal
Yeast Malassezia Triggers a Type 17 Response that Coordinates
Anti-fungal Immunity and Exacerbates Skin Inflammation. Cell Host
Microbe 2019; 25: 389-403.e386. 2019/03/15. DOI:
10.1016/j.chom.2019.02.002.
34. Li H, Goh BN, Teh WK, et al. Skin Commensal Malassezia globosa
Secreted Protease Attenuates Staphylococcus aureus Biofilm Formation.The Journal of investigative dermatology 2018; 138: 1137-1145.
2017/12/17. DOI: 10.1016/j.jid.2017.11.034.
35. Nakatsuji T, Chen TH, Narala S, et al. Antimicrobials from human
skin commensal bacteria protect against Staphylococcus aureus and are
deficient in atopic dermatitis. Sci Transl Med 2017; 9
2017/02/24. DOI: 10.1126/scitranslmed.aah4680.
36. Edslev SM, Andersen PS, Agner T, et al. Identification of cutaneous
fungi and mites in adult atopic dermatitis: analysis by targeted 18S
rRNA amplicon sequencing. BMC Microbiol 2021; 21: 72. 2021/03/06.
DOI: 10.1186/s12866-021-02139-9.
37. Savinko T, Matikainen S, Saarialho-Kere U, et al. IL-33 and ST2 in
atopic dermatitis: expression profiles and modulation by triggering
factors. The Journal of investigative dermatology 2012; 132:
1392-1400. 2012/01/27. DOI: 10.1038/jid.2011.446.
38. Scharschmidt TC, Vasquez KS, Truong HA, et al. A Wave of Regulatory
T Cells into Neonatal Skin Mediates Tolerance to Commensal Microbes.Immunity 2015; 43: 1011-1021. 2015/11/21. DOI:
10.1016/j.immuni.2015.10.016.
39. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode
shapes the acquisition and structure of the initial microbiota across
multiple body habitats in newborns. Proc Natl Acad Sci U S A2010; 107: 11971-11975. 2010/06/23. DOI: 10.1073/pnas.1002601107.
40. Xiong Z, Zhou L, Chen Y, et al. Prevalence of eczema between
cesarean-born and vaginal-born infants within 1 year of age: a
systematic review and meta-analysis. Eur J Pediatr 2022; 181:
2237-2247. 2022/03/19. DOI: 10.1007/s00431-022-04436-5.
41. Kennedy EA, Connolly J, Hourihane JOB, et al. Skin microbiome before
development of atopic dermatitis: Early colonization with commensal
staphylococci at 2 months is associated with a lower risk of atopic
dermatitis at 1 year. The Journal of Allergy and Clinical
Immunology 2017; 139: 166-166. DOI: 10.1016/J.JACI.2016.07.029.
42. Meylan P, Lang C, Mermoud S, et al. Skin Colonization by
Staphylococcus aureus Precedes the Clinical Diagnosis of Atopic
Dermatitis in Infancy. The Journal of investigative dermatology2017; 137: 2497-2504. 2017/08/27. DOI: 10.1016/j.jid.2017.07.834.
43. Nakamura Y, Takahashi H, Takaya A, et al. Staphylococcus Agr
virulence is critical for epidermal colonization and associates with
atopic dermatitis development. Sci Transl Med 2020; 12
2020/07/10. DOI: 10.1126/scitranslmed.aay4068.
44. Oh J, Conlan S, Polley EC, et al. Shifts in human skin and nares
microbiota of healthy children and adults. Genome Med 2012; 4:
77. 20121010. DOI: 10.1186/gm378.
45. Park J, Schwardt NH, Jo JH, et al. Shifts in the Skin Bacterial and
Fungal Communities of Healthy Children Transitioning through Puberty.The Journal of investigative dermatology 2022; 142: 212-219.
20210710. DOI: 10.1016/j.jid.2021.04.034.
46. Shi B, Bangayan NJ, Curd E, et al. The skin microbiome is different
in pediatric versus adult atopic dermatitis. J Allergy Clin
Immunol 2016; 138: 1233-1236. 2016/07/31. DOI:
10.1016/j.jaci.2016.04.053.
47. Wan M and Yang X. Maternal exposure to antibiotics and risk of
atopic dermatitis in childhood: a systematic review and meta-analysis.Front Pediatr 2023; 11: 1142069. 2023/05/31. DOI:
10.3389/fped.2023.1142069.
48. Ahmadizar F, Vijverberg SJH, Arets HGM, et al. Early-life antibiotic
exposure increases the risk of developing allergic symptoms later in
life: A meta-analysis. Allergy 2018; 73: 971-986. 2017/11/07.
DOI: 10.1111/all.13332.
49. Jo JH, Harkins CP, Schwardt NH, et al. Alterations of human skin
microbiome and expansion of antimicrobial resistance after systemic
antibiotics. Sci Transl Med 2021; 13: eabd8077. 2021/12/23. DOI:
10.1126/scitranslmed.abd8077.
50. Grech A, Collins CE, Holmes A, et al. Maternal exposures and the
infant gut microbiome: a systematic review with meta-analysis. Gut
Microbes 2021; 13: 1-30. 2021/05/13. DOI:
10.1080/19490976.2021.1897210.
51. Chiu LS, Ho MS, Hsu LY, et al. Prevalence and molecular
characteristics of Staphylococcus aureus isolates colonizing patients
with atopic dermatitis and their close contacts in Singapore. Br J
Dermatol 2009; 160: 965-971. 2009/02/19. DOI:
10.1111/j.1365-2133.2009.09038.x.
52. Chia M, Naim ANM, Tay ASL, et al. Shared signatures and divergence
in skin microbiomes of children with atopic dermatitis and their
caregivers. Journal of Allergy and Clinical Immunology 2022; 150:
894-908. DOI: 10.1016/j.jaci.2022.01.031.
53. Brito IL, Gurry T, Zhao S, et al. Transmission of human-associated
microbiota along family and social networks. Nature Microbiology
2019 4:6 2019; 4: 964-971. DOI: 10.1038/s41564-019-0409-6.
54. Hogan PG, Parrish KL, Mork RL, et al. HOME2 Study: Household Versus
Personalized Decolonization in Households of Children With
Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue
Infection—A Randomized Clinical Trial. Clinical Infectious
Diseases 2021; 73: e4568-e4577. DOI: 10.1093/CID/CIAA752.
55. Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin
microbiome associated with disease flares and treatment in children with
atopic dermatitis. Genome Res 2012; 22: 850-859. Research
Support, N.I.H., Extramural 2012/02/09. DOI: 10.1101/gr.131029.111.
56. Gonzalez ME, Schaffer JV, Orlow SJ, et al. Cutaneous microbiome
effects of fluticasone propionate cream and adjunctive bleach baths in
childhood atopic dermatitis. J Am Acad Dermatol 2016; 75:
481-493.e488. 2016/08/21. DOI: 10.1016/j.jaad.2016.04.066.
57. Khadka VD, Key FM, Romo-González C, et al. The Skin Microbiome of
Patients With Atopic Dermatitis Normalizes Gradually During Treatment.Front Cell Infect Microbiol 2021; 11: 720674. 2021/10/12. DOI:
10.3389/fcimb.2021.720674.
58. Hamid Q, Boguniewicz M and Leung DYM. Differential in situ cytokine
gene expression in acute versus chronic atopic dermatitis. The
Journal of clinical investigation 1994; 94: 870-876. DOI:
10.1172/JCI117408.
59. Neis MM, Peters B, Dreuw A, et al. Enhanced expression levels of
IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact
dermatitis. Journal of Allergy and Clinical Immunology 2006; 118:
930-937. DOI: 10.1016/j.jaci.2006.07.015.
60. Drucker AM, Ellis AG, Bohdanowicz M, et al. Systemic
Immunomodulatory Treatments for Patients With Atopic Dermatitis: A
Systematic Review and Network Meta-analysis. JAMA dermatology2020; 156: 659-667. DOI: 10.1001/JAMADERMATOL.2020.0796.
61. Press Release: FDA approves Dupixent® (dupilumab) as first biologic
medicine for children aged 6 months to 5 years with moderate-to-severe
atopic dermatitis - Sanofi.
62. Callewaert C, Nakatsuji T, Knight R, et al. IL-4Rα Blockade by
Dupilumab Decreases Staphylococcus aureus Colonization and Increases
Microbial Diversity in Atopic Dermatitis. The Journal of
investigative dermatology 2020; 140: 191-202.e197. DOI:
10.1016/J.JID.2019.05.024.
63. Beck LA, Bieber T, Weidinger S, et al. Tralokinumab treatment
improves the skin microbiota by increasing the microbial diversity in
adults with moderate-to-severe atopic dermatitis: analysis of microbial
diversity in ECZTRA 1, a randomized controlled trial. J Am Acad
Dermatol 2022 2022/12/07. DOI: 10.1016/j.jaad.2022.11.047.
64. Hussain M, Borcard L, Walsh KP, et al. Basophil-derived IL-4
promotes epicutaneous antigen sensitization concomitant with the
development of food allergy. J Allergy Clin Immunol 2018; 141:
223-234.e225. 2017/04/10. DOI: 10.1016/j.jaci.2017.02.035.
65. Galand C, Leyva-Castillo JM, Yoon J, et al. IL-33 promotes food
anaphylaxis in epicutaneously sensitized mice by targeting mast cells.J Allergy Clin Immunol 2016; 138: 1356-1366. 2016/07/04. DOI:
10.1016/j.jaci.2016.03.056.
66. Jones AL, Curran-Everett D and Leung DYM. Food allergy is associated
with Staphylococcus aureus colonization in children with atopic
dermatitis. J Allergy Clin Immunol 2016; 137: 1247-1248.e1243.
2016/03/11. DOI: 10.1016/j.jaci.2016.01.010.
67. Tsilochristou O, du Toit G, Sayre PH, et al. Association of
Staphylococcus aureus colonization with food allergy occurs
independently of eczema severity. J Allergy Clin Immunol 2019;
144: 494-503. 2019/06/05. DOI: 10.1016/j.jaci.2019.04.025.
68. Savinko T, Lauerma A, Lehtimäki S, et al. Topical superantigen
exposure induces epidermal accumulation of CD8+ T cells, a mixed
Th1/Th2-type dermatitis and vigorous production of IgE antibodies in the
murine model of atopic dermatitis. J Immunol 2005; 175:
8320-8326. 2005/12/13. DOI: 10.4049/jimmunol.175.12.8320.
69. Forbes-Blom E, Camberis M, Prout M, et al. Staphylococcal-derived
superantigen enhances peanut induced Th2 responses in the skin.Clin Exp Allergy 2012; 42: 305-314. 2011/11/19. DOI:
10.1111/j.1365-2222.2011.03861.x.
70. Leung DYM, Calatroni A, Zaramela LS, et al. The nonlesional skin
surface distinguishes atopic dermatitis with food allergy as a unique
endotype. Sci Transl Med 2019; 11 2019/02/23. DOI:
10.1126/scitranslmed.aav2685.
71. Kelleher MM, Cro S, Cornelius V, et al. Skin care interventions in
infants for preventing eczema and food allergy. Cochrane Database
Syst Rev 2021; 2: Cd013534. 2021/02/06. DOI:
10.1002/14651858.CD013534.pub2.
72. Zhong Y, Samuel M, van Bever H, et al. Reply to correspondence:
Emollients in infancy to prevent atopic dermatitis: A systematic review
and meta-analysis. Allergy 2022; 77: 1934-1935. 2022/06/02. DOI:
10.1111/all.15309.
73. Glatz M, Jo JH, Kennedy EA, et al. Emollient use alters skin barrier
and microbes in infants at risk for developing atopic dermatitis.PLoS One 2018; 13: e0192443. 2018/03/01. DOI:
10.1371/journal.pone.0192443.
74. Gueniche A, Knaudt B, Schuck E, et al. Effects of nonpathogenic
gram-negative bacterium Vitreoscilla filiformis lysate on atopic
dermatitis: a prospective, randomized, double-blind, placebo-controlled
clinical study. Br J Dermatol 2008; 159: 1357-1363. 2008/09/18.
DOI: 10.1111/j.1365-2133.2008.08836.x.
75. Paharik AE, Parlet CP, Chung N, et al. Coagulase-Negative
Staphylococcal Strain Prevents Staphylococcus aureus Colonization and
Skin Infection by Blocking Quorum Sensing. Cell Host Microbe2017; 22: 746-756.e745. 2017/12/05. DOI: 10.1016/j.chom.2017.11.001.
76. Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate
Toll-like receptor 3-dependent inflammation after skin injury. Nat
Med 2009; 15: 1377-1382. 2009/12/08. DOI: 10.1038/nm.2062.
77. Zheng Y, Hunt RL, Villaruz AE, et al. Commensal Staphylococcus
epidermidis contributes to skin barrier homeostasis by generating
protective ceramides. Cell Host Microbe 2022; 30: 301-313.e309.
2022/02/07. DOI: 10.1016/j.chom.2022.01.004.
78. Cau L, Williams MR, Butcher AM, et al. Staphylococcus epidermidis
protease EcpA can be a deleterious component of the skin microbiome in
atopic dermatitis. J Allergy Clin Immunol 2021; 147:
955-966.e916. 2020/07/08. DOI: 10.1016/j.jaci.2020.06.024.
79. Nakatsuji T, Hata TR, Tong Y, et al. Development of a human skin
commensal microbe for bacteriotherapy of atopic dermatitis and use in a
phase 1 randomized clinical trial. Nat Med 2021; 27: 700-709.
2021/02/24. DOI: 10.1038/s41591-021-01256-2.
80. Myles IA, Earland NJ, Anderson ED, et al. First-in-human topical
microbiome transplantation with Roseomonas mucosa for atopic dermatitis.JCI insight 2018; 3 2018/05/04. DOI: 10.1172/jci.insight.120608.
81. Shimamori Y, Pramono AK, Kitao T, et al. Isolation and
Characterization of a Novel Phage SaGU1 that Infects Staphylococcus
aureus Clinical Isolates from Patients with Atopic Dermatitis.Curr Microbiol 2021; 78: 1267-1276. 2021/02/28. DOI:
10.1007/s00284-021-02395-y.
82. de Wit J, Totté JEE, van Mierlo MMF, et al. Endolysin treatment
against Staphylococcus aureus in adults with atopic dermatitis:
A randomized controlled trial. J Allergy Clin Immunol 2019; 144:
860-863. 2019/05/31. DOI: 10.1016/j.jaci.2019.05.020.